FILE - In this image provided by the Serum Institute of India, vials of freshly manufactured Novavax COVID-19 vaccines wait to be labeled in 2022, in Pune, India. The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday, July 13, 2022, cleared Novavax shots for adults. (Serum Institute of India for Novavax via AP)

EU finds Novavax COVID vaccine may cause severe allergic reaction

A top government regulator has warned the Novavax COVID-19 vaccine may cause severe allergic reactions.On Thursday, the European Medicines Agency said they have had “a few cases” of anaphylaxis in connection with the vaccine and will be adding the potential side effect to the product’s information.